CCL20 and eosinophilia-myalgia syndrome: In conclusion, the CCL20/CCR6 axis mediates macrophages to promote the proliferation and migration of ESCs by blocking TFEB-mediated lysosomal degradation of autophagic flux in EMs, and it might be a novel target for EMs treatment.